28.3 C
Vientiane
Wednesday, July 9, 2025
spot_img
Home Blog Page 36

Henderson Land Sets Record for Central’s Largest Single Office Lease

New Central Harbourfront Site 3 Project Leases Over 70% of Phase 1 Office Premises


HONG KONG SAR – Media OutReach Newswire – 18 June 2025 – Henderson Land Development Company Limited (“Henderson Land” or “The Group”) (Stock code 12) is delighted to announce that, through its subsidiary, it has entered into an Agreement for Lease with Jane Street, a quantitative trading firm and liquidity provider, as the first anchor tenant of the Group’s latest New Central Harbourfront flagship development project. Jane Street will occupy over 223,000 square feet across six floors, leasing over 70% of the development’s Phase 1 premium office and ancillary space. The signing of the lease is nearly two years ahead of the anticipated handover in early 2027. This lease marks the largest single office leasing transaction for Hong Kong’s Central Business District in decades.

Aerial view of the project from Connaught Road to the harbourfront
Aerial view of the project from Connaught Road to the harbourfront

Chairman of Henderson Land, Dr. Martin Lee Ka-shing, said: “We are proud to welcome Jane Street to our New Central Harbourfront flagship development project.” He added, “Deeply rooted in Hong Kong, our Group is committed to advancing the city’s core districts, and this anchor tenancy reinforces Hong Kong’s unrivalled position as an international financial powerhouse. This development will reinvent Central by connecting the multi-worlds of retail, culture and commerce with nature and entertainment. Fuelled by the passion of our talented teams, we are confident that this global development will connect Hong Kong to the world stage, forging a bold new chapter for the city’s future.”

The New Central Harbourfront project spans over 1.6 million square feet of gross floor area. This transformative project will not only redefine the city’s iconic skyline, but also elevate Central as a cutting edge, vibrant global district.

The 400 meter-long development includes 700,000 square feet of office and ancillary space that offers the largest premium Grade-A Office floor plates in Central, 900,000 square feet of retail space and the first Broadway-calibre theatre in Central.

Inspired by a concept of “The Bridge”, this people-centric development is a superconnector that seamlessly bridges Hong Kong and the world, enhances connectivity in Central and fosters integration with its surroundings – strengthening synergies between urban and nature, commerce and culture. The development provides an unprecedented 300,000 square feet of green and open spaces, including a rooftop garden for public enjoyment. It links Central district’s vibrancy to the waterfront and the iconic Victoria Harbour, forming the new heart of Central. The site will unfold in two phases, with Phase 1 set for completion in the fourth quarter of 2026, and Phase 2 in 2032.

Two years ahead of its first phase opening, the project has earned the highest standard industry certifications for its sustainability-focused architectural design, including awards and accreditations from LEED, BEAM Plus, WiredScore, Construction Industrial Council (CIC), Green Business Certification Inc., The Hong Kong Institute of Surveyors and Hong Kong Green Building Council.

Hashtag: #HendersonLand

The issuer is solely responsible for the content of this announcement.

About Henderson Land Group

Founded in 1976 and listed in Hong Kong since 1981, Henderson Land Development Company Limited (Stock code: 12) is a leading property group, focusing on Hong Kong and mainland China. Henderson Land is carrying on its legacy into the future, curating a property portfolio that grows from strength to strength and encompasses award-winning landmark projects such as the International Finance Centre complex and The Henderson.

In addition to its core business in property development and property investment, the Group holds strategic investments in two listed subsidiaries (namely, Miramar Hotel and Investment Company Limited and Henderson Investment Limited) and three listed associates (namely, The Hong Kong and China Gas Company Limited (which in turn has equity stakes in a listed subsidiary, Towngas Smart Energy Company Limited), Hong Kong Ferry (Holdings) Company Limited and Sunlight Real Estate Investment Trust).

Henderson Land is dedicated to the long-term commitment of sustainability and is a pioneer in green building and sustainable practices, which harness innovation and technology to create new, smarter living. The Group is also a strong advocate of social responsibility and invests in a broad range of community causes and initiatives. For more information, please visit .

About Jane Street

Jane Street is a global quantitative trading firm and liquidity provider with expertise in a wide range of financial products, including ETFs, equities, futures, commodities, options, bonds, and currencies. Founded in 2000, Jane Street has offices in New York, London, Hong Kong, Amsterdam, and Singapore. Jane Street’s global footprint allows it to make markets continually on more than 200 electronic exchanges and other trading venues in more than 45 countries around the world.

The 17th Straits Forum Held in Xiamen, China: Promoting Cross-Strait Folk Exchanges and Integrated Development


XIAMEN, CHINA – Media OutReach Newswire – 18 June 2025 – The opening ceremony of the 17th Straits Forum was held in the morning of the 15th in Xiamen City, Fujian Province, China. As the largest-scaled, widest-ranging and most influential folk exchange event across the Taiwan Strait, guests from both sides of the Taiwan Strait gathered together to discuss the beautiful vision of cross-Strait exchanges and cooperation.

1

This session of the Straits Forum focused on the theme of “Expanding Folk Exchanges and Deepening Integrated Development”. It set up four major sections, namely grassroots exchanges, youth exchanges, cultural exchanges, and economic exchanges, with 56 series of activities arranged. The main venue of the forum was in Xiamen, while related activities were held in relevant prefecture-level cities in Fujian and the Pingtan Comprehensive Experimental Zone. More than 7,000 people from all walks of life in Taiwan were invited to participate.

Ma Ying-jeou, the former chairperson of the Kuomintang who attends the Straits Forum for the first time, stated in his speech at the meeting that the peaceful development of cross-Strait relations is the common aspiration of people on both sides of the Taiwan Strait. The natural bond of Chinese people on both sides, who share the same roots and origin, cannot be severed, and non-governmental exchanges across the Strait are unstoppable.

Currently, Fujian is steadfastly expanding economic and trade cooperation across the Taiwan Strait, deepening folk exchanges between Fujian and Taiwan, and enhancing the well-being of Taiwan compatriots, so as to make new contributions to the great cause of promoting the reunification of the motherland. Zhou Zuyi, Secretary of the Fujian Provincial Committee of the Communist Party of China, said, “We warmly welcome our Taiwan compatriots to actively participate in building the Cross-Strait Integrated Development Demonstration Zone. Let us move forward together, work hand in hand, and jointly seize development opportunities to share the fruits of integration”

Xiamen has earnestly implemented the Opinions of the Central Committee of the Communist Party of China and the State Council on Supporting Fujian in Exploring a New Path for Cross-Strait Integrated Development and Building a Cross-Strait Integrated Development Demonstration Zone. It continues to take the lead in piloting innovations for cross-strait integrated development, promoting integration through connectivity, preferential policies, and emotional bonds, so as to create more development opportunities and broader space for Taiwan compatriots.

It is reported that the Straits Forum has been successfully held for 16 sessions, with nearly 800 activities of various types carried out. A total of more than 350,000 person-times of compatriots from both sides of the Taiwan Strait have participated, among whom over 140,000 person-times are Taiwan compatriots. The Straits Forum has effectively played an important role in expanding cross-Strait folk exchanges and deepening cross-Strait integrated development.

Hashtag: #ChineseHeadlinesNewMedia

The issuer is solely responsible for the content of this announcement.

After Four Months Under Wraps, F.F.O Sets to Unveil New MV《大丈夫》from Japan Ski Trip


TAIPEI, TAIWAN – Media OutReach Newswire – 18 June 2025 – Emerging as champions of the hit Taiwanese talent show《Atom Boyz 2》, the boy group F.F.O officially debuted at the end of 2024 during the Graduation Concert. Their debut track《腦袋漂流記》received glowing reviews from fans, and their first album, now available for pre-order, has already seen impressive sales. With strong fan support at every appearance, from pop-up events to brand promotions, F.F.O is quickly becoming one of Taiwan’s most popular new idol groups. Their popularity even reached Japan, with digital billboards in Shinjuku drawing fans eager to catch a glimpse of the group.

F.F.O traveled to Niigata, Japan to film the music video for “It’s Alright.”
F.F.O traveled to Niigata, Japan to film the music video for “It’s Alright.”

Just two months after their debut, F.F.O was invited to Japan to collaborate with renowned ski brand Ski Addicts as ambassadors for a special ski campaign. The members went to Echigo-Yuzawa for a 6-day skiing trip. Not only did they enjoy the snow scene to the fullest, the group also surprised fans by shooting a brand-new music video《大丈夫》. With a tight schedule and nonstop energy, F.F.O showed remarkable dedication and professionalism.

The 《大丈夫》 MV is styled as a travel diary with a carefully written story behind it, capturing the group’s most authentic moments. Fans will see the members handing out their group logo stickers in Akihabara, bravely introducing themselves to locals while having their most genuine reaction captured by cameras. Of course, their snow-filled adventures also made it into the MV—featuring playful snowball fights, GoPro-filmed moments, and even ice cream in the freezing cold. The result is a heartfelt visual journey that feels like a personal postcard from F.F.O to their fans.

The MV was entirely shot in Japan. It captures the romantic encounter between F.F.O and the snow, and the highlights and memories of the Journey. “This MV is like a snapshot of our trip, full of fun and challenges. Stay tuned!” the members shared. The MV shoot spanned both Tokyo and Niigata, meaning that the F.F.O members had to rush between locations day and night. Not only did they finish the MV shooting in Akihabara and Echigo-Yuzawa, they even squeezed in a final shoot at Ueno Park for social media content just a day before they returned to Taiwan. Despite the intense schedule and freezing temperatures, they still gave it their all and showed impeccable professionalism to deliver the best possible visuals to their dedicated fans.

Now, several months after the shoot, F.F.O is thrilled to finally share《大丈夫》with fans. More behind the scenes footage and details will be revealed soon, so fans are encouraged to pay close attention to F.F.O’s official social media accounts to witness the exciting results of their very first trip since debut!

Hashtag: #F.F.O

The issuer is solely responsible for the content of this announcement.

Bee Choo Origin Celebrates 25th Anniversary with CEO Succession and Mascot Reveal


SINGAPORE – Media OutReach Newswire – 18 June 2025 – Home-grown herbal hair care brand Bee Choo Origin commemorated its 25th anniversary with a glittering annual dinner held at Goodwood Park Hotel. Themed Shimmer & Shine: A Silver Jubilee Celebration, the evening was marked by heartfelt tributes, prestigious awards, and three significant milestones—a CEO succession ceremony, the official debut of the brand’s first-ever mascots, and the launch of a new product.

Bee Choo Origin Celebrates 25th Anniversary with CEO Succession and Mascot Reveal
Bee Choo Origin Celebrates 25th Anniversary with CEO Succession and Mascot Reveal

A New Chapter: CEO Succession Ceremony

One of the most emotional and memorable moments of the 25th anniversary celebration was the CEO succession ceremony, a heartfelt passing of the torch from one generation to the next. Founder and outgoing CEO, Mdm Cheah Bee Chew, officially entrusted the future of Bee Choo Origin to her daughter, Estee Lim Xue Ting, who now assumes the role of Chief Executive Officer.

Estee’s journey with the brand is a testament to perseverance and purpose. A qualified optometrist by training, Estee initially pursued a career in the primary eye care sector before deciding to join her mother in managing the growing herbal hair care business. In 2024, she further deepened her expertise by becoming a certified trichologist, earning her accreditation from the International Association of Trichologists.

Over the past nine years, Estee has played an instrumental role in driving the evolution of Bee Choo Origin, spearheading digital transformation, introducing innovative product lines, refreshing the brand identity, and expanding its presence both online and across international markets.

In a deeply moving speech, Mdm Cheah shared, “At 65, I’ve come to realise that the greatest legacy is not in leaving behind an empire, but in raising a successor who surpasses you.” Her words captured the spirit of the evening, one filled with pride, gratitude, and hope for the future. The ceremonial handover included a symbolic gold key, brought on stage by the company’s newly introduced mascot, Manny, a figure inspired by the Ginseng herb, known for strength and resilience.

Estee’s appointment as CEO at the 25th anniversary dinner marks a significant milestone in the company’s 25-year journey. It reflects the brand’s confidence in her vision and commitment to continuous growth while remaining grounded in its founding values of integrity, care, and natural wellness. With Estee at the helm, Bee Choo Origin is poised to usher in a new chapter, one that blends tradition with innovation and heritage with forward-thinking leadership.

A Glimpse Into the Future: New Product Announcement

In line with the celebratory theme of innovation and growth, Bee Choo Origin also unveiled a new addition to its product lineup during the gala dinner—The Finest Dead Sea Mud Scalp Mask. This in-store treatment combines the mineral-rich properties of Dead Sea mud with the Bee Choo Essence, the brand’s signature blend of herbal actives, to offer deep-cleansing and revitalising benefits.

Slated to launch later this year exclusively as a professional in-store treatment, the scalp mask is designed to work synergistically with Bee Choo Essence to enhance scalp detoxification, encourage healthy circulation, and help maintain overall scalp balance. Developed as a natural, chemical-free solution, it reflects the brand’s continued focus on providing a holistic and elevated treatment experience for customers.

“This new scalp mask reflects our dedication to continuous innovation while staying true to our herbal roots,” Estee shared. “By combining the therapeutic properties of Dead Sea mud with our trusted Bee Choo Essence, we’re offering a treatment that is not only indulgent but deeply effective.”

Introducing the Bee Choo Origin Mascot Family

To further commemorate its 25th anniversary, Bee Choo Origin unveiled its delightful new mascot series, each representing a key ingredient used in its signature herbal hair treatments. The mascots — Manny (Ginseng), Ling Zy (Ling Zhi), Hei (He Shou Wu), and Dango (Dang Gui) — bring warmth, character, and a playful spirit to the brand.

“These mascots are more than just adorable figures,” Estee shared. “They symbolise who we are, natural, full of life, and deeply rooted in heritage. This new direction helps us stay relatable and build stronger emotional bonds with our customers.” The mascots will feature prominently in marketing campaigns, social media, merchandise, and educational materials.

As Bee Choo Origin celebrates its 25th anniversary, it reaffirms its commitment to holistic, herbal-based hair solutions while looking boldly ahead. With Estee as the CEO and the mascot family as its new brand ambassadors, the company is poised to soar to new heights.

Hashtag: #BeeChooOrigin



The issuer is solely responsible for the content of this announcement.

About Bee Choo Origin

Founded with a mission to restore scalp health naturally, Bee Choo Origin has grown into Asia Pacific’s leading herbal hair and scalp care brand. With humble beginnings rooted in a commitment to safe, effective, and natural treatments, the brand now operates an estimated 180 outlets across around 10 territories in the Asia-Pacific region. This includes 7 directly owned stores and 14 distributor-managed outlets in Singapore, around 40 in Malaysia, and the remainder through a network of distributors in key regional markets. Specialising in the treatment of hair loss, dandruff, oily or and other common hair concerns, Bee Choo Origin is consistently recognised as one of the top natural salons in the region. Combining traditional wisdom with modern care, Bee Choo Origin continues to serve individuals seeking a holistic, chemical-free solution to hair and scalp issues, offering visible results, authentic care, and peace of mind with every visit.

Correcting and Replacing: Visa unveils Flex Credential in Vietnam, ushering in a new era of payment flexibility and financial empowerment for consumers

  • Vietnam leads Southeast Asia in financial confidence and readiness for major purchases, Visa survey
  • With Visa Flex Credential, consumers can seamlessly choose how they pay, via credit, debit, and more, all on a single credential, redefining the future of payments

HCMC, VIETNAM – Media OutReach Newswire – 17 June 2025 – Visa (NYSE: V), a global leader in digital payments, announced the launch of Visa Flex Credential, offering new ways for consumers to manage and spend their money, with Asia Commercial Joint Stock Bank (ACB) becoming the first bank in Vietnam – and Southeast Asia – to offer this feature. Starting today, ACB Visa cardholders can seamlessly switch between debit and credit cards via the ACB One app. By the end of 2025, additional issuers will expand Visa Flex Credential to more Vietnamese consumers, enabling expanded use-cases.

Visa Flex Credential - ACB One app

According to Visa’s latest Green Shoots Radar survey[1], Vietnamese consumers, especially Gen Z and Millennials, lead Southeast Asia in financial confidence and ambition. Today’s young Vietnamese are prioritising investments in education (66%), healthcare (65%), electronics (63%), and travel (61%), showing a readiness to make big-ticket purchases and take control of their financial futures.

Visa Flex Credential is reimagining the credential for the next generation, designed to put the power of choice directly in consumers’ hands at every transaction – enabling them to opt for debit on daily purchases, credit for larger expenses, or even redeeming loyalty points when checking out, whether it’s for everyday essentials or a dream vacation.

“Visa is committed to empowering consumers with innovative solutions that put them in control of their financial future. Flex Credential is Visa’s breakthrough solution that enables the integration of multiple funding sources through a single card credential, providing cardholders with maximum flexibility to efficiently manage and utilize their payment forms. In specific markets such as the U.S. and UAE, Visa Flex Credential allows cardholders to choose to pay now or pay over time directly from the app, as well as access multiple currency accounts through a single credential – making cross-border payments simple and seamless. We are proud to bring this solution to Vietnam, making digital payments more accessible and contributing to Vietnam’s digital and financial inclusion and overall economic growth,” said Ms. Dung Dang, Visa Country Manager for Vietnam & Laos.

Mr. Nguyen Tam Khoa, Deputy Head of Consumer Division at ACB, shared: “The Visa Flex Credential truly speaks for itself, elevating the customer experience to a new level. While there are quite a few similar solutions in the market, the Visa Flex Credential stands out by meeting all customer needs, such as flexible payment source selection, a variety of transaction methods from offline to online, and the ability to choose from a wide range of suitable offers, all while ensuring independent, clear, and transparent spending management for each card.”

Visa first launched Flex Credential in partnership with Sumitomo Mitsui Banking Corporation (SMBC) and Sumitomo Mitsui Card Company (SMCC), known as Olive, two years ago in Japan. Today, more than 5 million Olive account holders are benefitting from the Visa Flex Credential. The Olive card continues to outperform, with cardholder transactions averaging 40% higher than the national average in Japan over the past year. Visa and SMCC have expanded the Visa Flex Credential to support small businesses with the flexibility to switch between business and personal accounts using the same Olive card, enhancing access to credit and cash flow management.

Key features of Visa Flex Credential:

  • Customisable payment options: Switch effortlessly between payment modes, such as debit, credit, prepaid, loyalty points etc. to suit different spending needs and having one credential for life.
  • Advanced security protocols: Benefit from Visa’s latest security technologies to stay protected against fraud.
  • Personalised insights and control: Use AI-driven insights to better manage your finances and spending habits.
  • Unified payment experience: Manage all your financial transactions through a single, easy-to-use platform.

Visa and ACB are proud partners of Cashless Day 2025, demonstrating their commitment to promoting digital payment solutions in Vietnam. This collaboration further highlights their shared vision of fostering economic empowerment through innovative technology.


[1] The Green Shoots Radar study is conducted quarterly by Visa to track consumer sentiments across financial services, commerce, travel, and other categories. The total sample size is 14,250 respondents across 14 Asia-Pacific countries, including Vietnam, with male and female participants aged 18 to 65 years old.

Hashtag: #Visa #VisaFlexCredential #DigitalEconomy #AsiaCommercialJointStockBank(ACB) #ACBOneApp

The issuer is solely responsible for the content of this announcement.

About Visa

Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at .

Railtown AI Technologies Inc. Announces Strategic Partnership with Quantum.IQ and Private Placement

Vancouver, British Columbia – Newsfile Corp. – June 17, 2025 – Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) (“Railtown” or the “Company”) a leading innovator in AI-driven developer solutions, is pleased to that its wholly owned subsidiary, Railtown AI Tool Corporation, has entered into a licensing agreement with Quantum.IQ AI Technologies Inc. (“Quantum.IQ”). This marks the beginning of a strategic partnership aimed at expanding Railtown’s Application General Intelligence™ platform into the rapidly evolving field of quantum computing infrastructure and development. The partnership will specifically extend Railtown’s Conductor platform to power a first-of-its-kind hybrid quantum cloud platform, designed to assist developers in seamlessly integrating quantum computing into real-world applications.

Under the agreement, Quantum IQ will license and extend the Railtown Conductor platform to enable intelligent orchestration between classical and quantum computation resources. The system will help developers identify, transition, and optimize sections of workloads for quantum execution, while maintaining critical non-quantum components on all traditional infrastructure, whether local hardware systems, public-cloud infrastructure, or on accelerated AI platforms such as CoreWeave.

Quantum.IQ’s platform will serve as a critical enabler of the emerging quantum-ready software development lifecycle (Q-SDLC), offering developers a comprehensive toolkit to bridge the complexity gap between classical and quantum systems. The platform will include modules for code analysis, algorithm optimization, runtime observability, and workload decomposition — all powered by Railtown’s agentic AI framework.

“We built Conductor to enable adaptive, AI-driven software systems,” said Cory Brandolini CEO of Railtown AI. “Quantum IQ is using that foundation to tackle one of the most significant frontiers in computing — and we’re thrilled to support them. As quantum moves from theory to practical utility, the tooling for real-world development needs to keep pace. With Railtown’s infrastructure, Quantum.IQ will build a platform that allows developers to engage with quantum computing meaningfully, not as a separate discipline, but as an extension of existing workflows.”

A cornerstone of the Quantum.IQ platform will be “quantum observability,” providing developers with detailed insight into application performance across both classical and quantum layers. This functionality is expected to unlock new opportunities for hybrid application design in sectors including finance, logistics, climate modeling, and advanced research. Quantum.IQ plans to integrate with current quantum cloud providers such as IBM Quantum and D-Wave, alongside scalable infrastructure from the largest computing industry “hyperscalers” and AI-native compute platforms.

A developer preview version of Quantum.IQ’s platform is planned to be available later this year.

Additionally, Railtown would like to announce a strategic investment via private placement of 1,200,000 units at $0.50 raising $600,000; each unit shall consist of 1 common share and one-half of a common share purchase warrant exercisable at $0.75 for a period of 18 months from closing.

About Railtown AI Technologies Inc.

Railtown AI Technologies is a leading provider of developer productivity engineering platforms powered by artificial intelligence. Its flagship Application General Intelligence™ platform helps organizations streamline software development, reduce time-to-resolution, and scale innovation with automated root cause analysis, performance optimization, and intelligent workflow automation.

About Quantum.IQ AI Technologies Inc.

Quantum.IQ is a private Canadian company driven building the next generation of quantum-AI hybrid computing solutions. The company’s proprietary quantum software development platform enables intelligent orchestration between classical and quantum computation resources. The system will help developers identify, transition, and optimize sections of workloads for quantum execution and assist the development of next-generation simulation environments, and AI-assisted tools that advance quantum research and commercial deployment.

Follow us on social media

SUBSCRIBE FOR INVESTOR NEWS

Click here to receive our latest investor news alerts.

ON BEHALF OF THE BOARD
“Cory Brandolini”
Cory Brandolini, Chief Executive Officer

INVESTOR CONTACT
Rebecca Kerswell
Investor Relations Contact
Email: investors@railtown.ai
Phone: 1-604-417-4440

This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will,” “may”, “should”, “intends”, “anticipates”, “expects” and similar expressions. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding the future plans and objectives of the Company, the commencement of trading of the Company’s common shares on the CSE, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulators.

Readers are cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, the Company cannot guarantee that any forward-looking statement will materialize, and readers should not place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward-looking statements as expressly required by Canadian securities law.

***NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR
DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES.***

The issuer is solely responsible for the content of this announcement.

HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong’s Life & Health Innovations at BIO International Convention

Seizing Global Business and Investment Opportunities for Sustainable Growth


HONG KONG SAR – Media OutReach Newswire – 17 June 2025 – Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK, led 16 prominent life and health technology companies to BIO 2025, the world’s largest biotechnology event, held in Boston, USA, from June 16 to 19. This year marks the first time HKSTP joined forces with Hong Kong’s two leading medical faculties—the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) – to form a delegation, showcasing Hong Kong’s cutting-edge research capabilities and innovation potential in life sciences and health technologies. The initiative further strengthens Hong Kong’s position as a world-class biotech innovation hub.

In collaboration with InvestHK, HKSTP joined forces with the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) for the first time to form a delegation and led 16 prominent life and health technology companies to showcase at BIO 2025 held in Boston, USA.
In collaboration with InvestHK, HKSTP joined forces with the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) for the first time to form a delegation and led 16 prominent life and health technology companies to showcase at BIO 2025 held in Boston, USA.

The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP’s incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms.

During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities:

  • Immuno Cure, partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX.
  • HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth.

Mr. Albert Wong, CEO of HKSTP, said: “We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong’s breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation.”

Ahead of BIO 2025, the delegation participated in the “2025 Biomedical Pitch Competition”, co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies—ARBELE, GenEditBio, and Cogsmart—excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed’s affiliated spin-off company, winning the championship, underscoring Hong Kong’s research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth.

HKSTP is committed to propelling Hong Kong’s life sciences sector onto the global stage, showcasing the city’s unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as “Edison of Medicine”), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong’s sustainable development in life sciences and its role as a global innovation leader.

Appendix: List of Park Companies Participating in BIO 2025:

  1. Allegrow Biotech Limited
  2. ARBELE Limited
  3. Beth Bioinformatics Co., Limited
  4. Centre for Translational Stem Cell Biology
  5. The Centre for Virology, Vaccinology, and Therapeutics
  6. DECODE CURE Limited
  7. GenEditBio Limited
  8. Great Bay Bio
  9. Hong Kong Universal Biologicals Company Limited
  10. Immuno Cure Holding (HK) Limited
  11. The Institute for Innovation, Translation and Policy Research (ITPR)
  12. LEE’S PHARMACEUTICAL (HK) LIMITED
  13. Serilink Biotechnology Company Limited
  14. Xiaomo Biotech Limited
  15. XUXIN (HongKong) Biotechnology Co., Limited
  16. Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited

Hashtag: #HKSTP

The issuer is solely responsible for the content of this announcement.

About Hong Kong Science and Technology Parks Corporation

Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 15,000 research professionals and over 2,300 technology companies from 25 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.

Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.

Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.

Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in stablishing I&T as a pillar of growth for Hong Kong. More information about HKSTP is available at .

Hong Kong Baptist University and Elsevier Report Charts Global Growth of Chinese Medicine Research, Calls for Standardised Frameworks for Broader Integration


ISTANBUL, TURKEY – Media OutReach Newswire – 17 June 2025 – The report “Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine” released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, “Chinese Medicine research” encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field’s rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine.

HKBU and Elsevier launched a new report "Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine", highlighting the growing global impact of Chinese Medicine research in diversified healthcare solutions.
HKBU and Elsevier launched a new report “Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine”, highlighting the growing global impact of Chinese Medicine research in diversified healthcare solutions.

Key findings from the report include:

  • Rapid expansion: Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023.
  • High scholarly impact: 14.2% of Chinese Medicine papers ranked among the world’s top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12.
  • Interdisciplinary breadth: Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science.
  • Global collaboration hubs: Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications.
  • Emerging research foci: Top-published trending topics include “Herbaceous Agent | Chinese Medicine | Network Pharmacology” and COVID-19 applications, reflecting integration of omics, AI and systems methods.
  • Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest.

Bridging a global integration gap

Chinese Medicine’s mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact.

“‘Evolving Legacy’ demonstrates how Chinese Medicine research has matured into a global, evidence-informed field,” said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine. “We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.”

“This report offers unprecedented insights into Chinese Medicine’s evolving scientific landscape,” added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. “It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health.”

The report was developed using Elsevier’s bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on https://cm-evaluation.scm.hkbu.edu.hk/.

Hashtag: #HKBU

The issuer is solely responsible for the content of this announcement.